Forehead Wrinkles Clinical Trial
Official title:
A Multi-center Acute Efficacy Trial of GFX For Reduction of Glabellar Furrowing
The purpose of this research study is to evaluate the immediate effectiveness of the GFX™ device in reducing the furrows (deep frown lines) between eyebrows (glabellar region).
The purpose of this research study is to evaluate the acute ability of GFX to reduce
glabellar furrowing.
Patients who have presented to the investigator for correction of glabellar furrows, as
classified per the Rated Numeric Kinetic Line Scale Score for Facial Wrinkles Secondary to
Hyperkinetic Function (Note: Class 1 or Higher)7 (Appendix N) are candidates for this study.
All patients must consent to the procedure and agree to complete their post treatment
evaluation visit.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01950065 -
Effectiveness and Safety Study of the Iovera Device for the Temporary Reduction in the Appearance of Forehead Wrinkles
|
N/A | |
Completed |
NCT03799484 -
Botulinum Toxin Type A Injection After Topical Anesthesia Versus Petrolatum Ointment
|
Phase 4 |